Skip to main content
. 2018 Oct 30;266(1):57–67. doi: 10.1007/s00415-018-9092-4

Fig. 3.

Fig. 3

ad Mean absolute cell count (cells/µl) of T -(CD4+, CD8+, CD4+/CD8+) and natural killer- (NK-) cells (CD56+CD16+). Baseline represents the last available cell count before each cycle of rituximab. Cell counts are summarized in 3-month intervals